Table 2. Exploratory analysis from the anthracycline in early breast cancer trials.
Abbreviations: CI, confidence interval; HR, hazard ratio; IDFS, invasive disease‐free survival; TaxAC, taxane‐containing adjuvant regimen; TC, taxane, cyclophosphamide.